O36.119
Maternal care for Anti-A sensitization, unspecified trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Maternal care for Anti-A sensitization (ICD-10 code O36.119) pertains to medical attention provided to pregnant women who have developed antibodies against the A blood group antigen. This condition can pose risks to the pregnancy, particularly affecting the fetus. Proper monitoring and management are essential to prevent complications and ensure the health of both mother and baby during pregnancy.
Causes & Symptoms
Clinical Causes: Previous pregnancy involving an A antigen-positive fetus Blood transfusions with A antigen-positive blood before pregnancy Blood incompatibility due to other medical conditions or blood transfusions Lack of prior exposure but developing sensitization during pregnancy
Key Symptoms: Usually none in the mother, as Anti-A sensitization often remains asymptomatic Potential signs include fatigue, weakness, or mild discomfort if complications arise In severe cases, signs of pregnancy complications such as anemia or preterm labor
Diagnostic & Treatment
Diagnosis Path: Diagnosis often involves blood tests that identify the presence of Anti-A antibodies in the mother's blood. These tests may include:
Treatment Protocols: Management of Anti-A sensitization during pregnancy focuses on monitoring and minimizing risks to the fetus. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is O36.119 a billable ICD-10 code?
Yes, O36.119 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.119?
Clinical documentation must specify the nature of Maternal care for Anti-A sensitization, unspecified trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference